Imatinib 400MG Tablets IP is a pharmaceutical product containing the active ingredient Imatinib. This medication belongs to a class of drugs known as tyrosine kinase inhibitors and is primarily used to treat specific types of cancers, notably chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and other malignancies. Imatinib works by blocking abnormal protein signals that drive the growth of cancer cells. These tablets come in various strengths and are typically taken orally. The precise dosage and treatment duration are determined by a healthcare provider. Patients should be aware of potential side effects and contraindications specific to their treatment. Imatinib Tablets IP should be used under the guidance of a qualified healthcare professional.
MARSHALL HEALTHCARE
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |